RESUMO
Therapeutic efficacies of various drugs were studied comparatively in the treatment of experimental plague in albino mice at the stage of the infection generalization. It was shown that out of the tested drugs such as ciprofloxacin, amikacin, gentamicin, rifampicin and polymyxin B only ciprofloxacin provided a rather high therapeutic effect in the treatment of the plaque septic form. The in vitro and in vivo experiments demonstrated that ciprofloxacin had an antitoxic action on lipopolysaccharide (LPS) and the plague microbe toxin. In comparison to ciprofloxacin, polymyxin B had a higher neutralizing activity. It was found that the efficacy of the experimental plague treatment at the stage of the infection generalization increased with the use of combinations of the drugs with antitoxic and antibacterial activities (ciprofloxacin and polymyxin B).
Assuntos
Anti-Infecciosos/uso terapêutico , Peste/tratamento farmacológico , Amicacina/uso terapêutico , Animais , Ciprofloxacina/uso terapêutico , Progressão da Doença , Avaliação Pré-Clínica de Medicamentos , Gentamicinas/uso terapêutico , Camundongos , Peste/patologia , Polimixinas/uso terapêutico , Rifampina/uso terapêuticoRESUMO
The effect of rifampicin on the plague microbe was studied in vitro and in albino mice with experimental plague infection. The rifampicin MIC with respect to 50 strains of the plague microbe of different origin in the tests on the Hottinger agar ranged from 1.6 to 6.4 micrograms/ml. High efficacy of rifampicin was shown in the prophylaxis and treatment of experimental plague when used in doses of 25 and 50 mg/kg once every 24 hours for 5 to 7 days. Rifampicin prevented the development of plague in at least 80 per cent of the albino mice when it was administered 1, 3, 6 and 24 hours prior to the infection. The antibiotic had a prolonged action and preserved its high efficacy after the administration at intervals of 48 and 72 hours.
Assuntos
Peste/prevenção & controle , Rifampina/uso terapêutico , Yersinia pestis/efeitos dos fármacos , Animais , Camundongos , Testes de Sensibilidade MicrobianaRESUMO
Activity of aminoglycosides such as gentamicin, sisomicin and amikacin against plague microbe strains of natural origin was studied in vitro. It was also studied in prophylaxis and treatment of experimental plague infection in albino mice. The MAC of gentamicin and sisomicin for 50 strains of the plague microbe was 0.2-1.6 micrograms/ml. For the majority of the strains it was 0.4 micrograms/ml. The amikacin MICs were 0.4-3.2 and 0.8 micrograms/ml, respectively. High efficacy of gentamicin, sisomicin and amikacin was shown in prophylaxis and treatment of experimental plague infection in albino mice. The optimal doses of the antibiotics were determined. Under definite conditions such as the use of short-term regimens and higher intervals, advantages of sisomicin over gentamicin and amikacin in prophylaxis of experimental plague infection were observed.